Skip to main content
. 2017 Dec 26;2017:4523673. doi: 10.1155/2017/4523673

Table 3.

Schirmer's test value in the treatment and placebo groups at baseline, 2 weeks, and 4 weeks after treatment.

Follow-up periods P value
Baseline 2 weeks 4 weeks P1 P2 P3
Treatment group (N = 25) 6.84 ± 1.03 6.92 ± 0.91 7.04 ± 1.49 0.99 0.98 0.98
Placebo group (N = 25) 6.56 ± 1.16 6.64 ± 1.08 6.91 ± 1.29 0.99 0.84 0.99
P value 0.50 0.42 0.87

P1 baseline versus 2 weeks; P2 baseline versus4 weeks; and P3 2 weeks versus 4 weeks.